Wearables as infrastructure

Wearable health devices are being treated less like gadgets and more like data systems that feed medicine, research, and care. (theverge.com) The shift is visible at Apple, where Tim Cook is set to become executive chairman on September 1, 2026, and John Ternus will become chief executive officer the same day. The Verge argued this week that Cook’s most durable product legacy may be the Apple Watch’s role in health tracking, not just consumer electronics. (apple.com) (theverge.com) Clinical research is moving the same way. A March 2026 review in *Nature Reviews Drug Discovery* said wearable technologies are increasingly being integrated into clinical trials to capture physiological and behavioral endpoints in real-world settings. (nature.com) In plain terms, a wearable turns steps, heart rate, sleep, temperature, or rhythm into a steady stream of measurements instead of a single reading in a clinic. That lets researchers watch what happens between visits, at home, during work, during sleep, and over weeks or months. (nature.com) (pmc.ncbi.nlm.nih.gov) Apple has spent years pushing the watch into regulated health functions. Apple says the electrocardiogram app can record heart rhythm on Apple Watch Series 4 or later, while irregular rhythm notifications check for signs of atrial fibrillation, and AFib History is available for people already diagnosed with the condition. (support.apple.com 1) (support.apple.com 2) (support.apple.com 3) The Food and Drug Administration has also cleared parts of that stack. An August 8, 2018 de novo decision classified Apple’s irregular rhythm notification feature as a Class II device for over-the-counter use with Apple Watch. (accessdata.fda.gov) Other wearable companies are building research programs around the same idea. Oura markets a research offering that says its ring delivers more than 30 biometrics for academic and medical studies, Fitbit Enterprise says researchers can use its devices, services, Google Cloud credits, and Fitabase support, and WHOOP runs WHOOP Labs for in-person and in-app studies. (organizations.ouraring.com) (fitbit.google) (whoop.com) (support.whoop.com) Fitbit’s research push is already tied to large-scale data sharing. A 2022 paper on the National Institutes of Health’s All of Us program described a bring-your-own-device study for collecting Fitbit data from participants and making those data available to registered researchers. (pmc.ncbi.nlm.nih.gov) The practical implication for software companies is that connections to Apple Watch, Oura, WHOOP, and Fitbit can look less like optional wellness features and more like long-lived infrastructure work. When the same devices are used by consumers, health systems, and trial sponsors, the integration can serve coaching, monitoring, and research from the same data pipe. (theverge.com) (nature.com) (fitbit.google) (organizations.ouraring.com) The limits are still real. Reviews of wearables in research point to recurring problems with validation, missing data, device selection, participant adherence, privacy, and whether a consumer device’s signal is reliable enough for a trial’s primary endpoint. (nature.com) (pmc.ncbi.nlm.nih.gov) That is why the category now looks more like infrastructure than fashion. The wristband or ring is still consumer hardware, but the enduring asset is the measurement layer underneath it. (theverge.com) (nature.com)